glp-1 drugs and crohn's disease Primer: The Skinny on GLP-1s Ozempic and IBD? Gastroenterologist examines
Description
Remove patch and discard
A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)
Purpose of Review GLP-1 receptor agonists (GLP-1RAs) have become central therapies for obesity and metabolic disease
Cinnamon & Gymnema help maintain blood sugar balance.*
Learn the most common side effects of GLP-1 medications, like nausea, fatigue and reflux, and find tips to manage them effectively.
